Burning Rock Biotech (BNR) Preferred Stock Liabilities (2019)

Burning Rock Biotech (BNR) posted quarterly Preferred Stock Liabilities of $216.7 million for Q4 2019.

Burning Rock Biotech (BNR) Preferred Stock Liabilities (2019) Analysis & Trends

Burning Rock Biotech's Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $216.7 million for Q4 2019.

  • In Q4 2019, Preferred Stock Liabilities changed N/A year-over-year to $216.7 million; the TTM figure through Dec 2019 stood at $216.7 million (changed N/A YoY), while the FY2019 annual figure was $221.2 million, changed N/A from the prior year.
  • Preferred Stock Liabilities for Q4 2019 stood at $216.7 million.
  • The five-year high for Preferred Stock Liabilities was $216.7 million in Q4 2019, with the low at $216.7 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn -
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn -
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn -
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn -
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn -
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn -
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn -
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn -
10 Burning Rock Biotech 781.17 Mn 711.04 Mn 11.31 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 216.66 Mn